Environmental-sensitive micelles based on poly(2-ethyl-2-oxazoline)-b-poly(L-lactide) diblock copolymer for application in drug delivery

被引:101
作者
Hsiue, Ging-Ho [1 ]
Wang, Chun-Hung
Lo, Chun-Liang
Wang, Chau-Hui
Li, Ju-Pi
Yang, Jia-Ling
机构
[1] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 300, Taiwan
[2] Ind Technol Res Inst, Polymer Technol Div, Union Chem Labs, Hsinchu 300, Taiwan
[3] Natl Tsing Hua Univ, Inst Biotechnol, Mol Carcinogenesis Lab, Hsinchu 300, Taiwan
[4] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan
关键词
poly(2-ethyl-2-oxazoline) (PEOz); poly(L-lactide) (PLLA); diblock copolymers; polymeric micelle; drug delivery;
D O I
10.1016/j.ijpharm.2006.03.002
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Anticancer drug doxorubicin (DOX) was physically loaded into the micelles prepared from poly(2-ethyl-2-oxazoline)-b-poly(L-lactide) diblock copolymers (PEOz-PLLA). PEOz-PLLA consists of hydrophilic segment PEOz and hydrophobic segment PLLA showed pH-sensitivity in the aqueous solution. The DOX-loaded micelle exhibited a narrow size distribution with a mean diameter around 170 nm. The micellar structure can preserve hydrophobic drug DOX under the physiological condition (pH 7.4) and selectively release DOX by sensing the intracellular pH change in late endosomes and secondary lysosomes (pH 4-5). At 37 degrees C, the cumulated released rate of DOX from micelles was about 65% at pH 5.0 in the initial 24 h. Additionally, polymeric micelles had low cytotoxicity in human normal fibroblast HFW cells for 72 h by using MTT assay. Moreover, DOX-loaded micelles could slowly and efficiency decrease cell viability of non-small-cell lung carcinoma CL3 cells. Taken together, PEOz-b-PLLA diblock polymeric micelles may act as useful drug carriers for cancer therapy. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 31 条
[1]
Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: Tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy [J].
Bae, Y ;
Nishiyama, N ;
Fukushima, S ;
Koyama, H ;
Yasuhiro, M ;
Kataoka, K .
BIOCONJUGATE CHEMISTRY, 2005, 16 (01) :122-130
[2]
BAE Y, 2005, ANGEW CHEM INT EDIT, V42, P4640
[3]
MICELLE FORMATION OF BAB TRIBLOCK COPOLYMERS IN SOLVENTS THAT PREFERENTIALLY DISSOLVE THE A-BLOCK [J].
BALSARA, NP ;
TIRRELL, M ;
LODGE, TP .
MACROMOLECULES, 1991, 24 (08) :1975-1986
[4]
Opposite roles of ERK and p38 mitogen-activated protein kinases in cadmium-induced genotoxicity and mitotic arrest [J].
Chao, JI ;
Yang, JL .
CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (09) :1193-1202
[5]
Inner core segment design for drug delivery control of thermo-responsive polymeric micelles [J].
Chung, JE ;
Yokoyama, M ;
Okano, T .
JOURNAL OF CONTROLLED RELEASE, 2000, 65 (1-2) :93-103
[6]
EINHORN LH, 1982, CANCER TREAT REP, V66, P2005
[7]
INVITRO CYTOTOXICITY OF LIPOSOME-ENCAPSULATED DOXORUBICIN - DEPENDENCE ON LIPOSOME COMPOSITION AND DRUG RELEASE [J].
HOROWITZ, AT ;
BARENHOLZ, Y ;
GABIZON, AA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1109 (02) :203-209
[8]
Polymeric micellar pH-sensitive drug delivery system for doxorubicin [J].
Hruby, M ;
Konák, C ;
Ulbrich, K .
JOURNAL OF CONTROLLED RELEASE, 2005, 103 (01) :137-148
[9]
DNA damage induced by micellar-delivered doxorubicin and ultrasound: comet assay study [J].
Husseini, GA ;
El-Fayoumi, RI ;
O'Neill, KL ;
Rapoport, NY ;
Pitt, WG .
CANCER LETTERS, 2000, 154 (02) :211-216
[10]
Polymeric micelles - a new generation of colloidal drug carriers [J].
Jones, MC ;
Leroux, JC .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 48 (02) :101-111